{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:37:41Z","timestamp":1793227061508,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:00:00Z","timestamp":1500076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:00:00Z","timestamp":1500076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RO1 NS099539"],"award-info":[{"award-number":["RO1 NS099539"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52111000"],"award-info":[{"award-number":["52111000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470999"],"award-info":[{"award-number":["81470999"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004751","name":"Department of S and T for Social Development","doi-asserted-by":"publisher","award":["2011ZX09102-004"],"award-info":[{"award-number":["2011ZX09102-004"]}],"id":[{"id":"10.13039\/501100004751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12035-017-0663-7","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T03:54:34Z","timestamp":1500090874000},"page":"4702-4717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice"],"prefix":"10.1007","volume":"55","author":[{"given":"Qingzhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng H.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-7931","authenticated-orcid":false,"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,15]]},"reference":[{"key":"663_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11883-016-0575-4","volume":"18","author":"T Mandviwala","year":"2016","unstructured":"Mandviwala T, Khalid U, Deswal A (2016) Obesity and cardiovascular disease: a risk factor or a risk marker? Curr Atheroscler Rep 18:21. doi:\n                    10.1007\/s11883-016-0575-4","journal-title":"Curr Atheroscler Rep"},{"key":"663_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000341287","volume":"73","author":"MI Goran","year":"2012","unstructured":"Goran MI, Alderete TL (2012) Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity. Nestle Nutr Inst Workshop Ser 73:49\u201360; discussion p61\u20136. doi:\n                    10.1159\/000341287","journal-title":"Nestle Nutr Inst Workshop Ser"},{"key":"663_CR3","doi-asserted-by":"publisher","unstructured":"Verma S, Hussain ME (2016) Obesity and diabetes: an update. Diabetes Metab Syndr. doi:\n                    10.1016\/j.dsx.2016.06.017","DOI":"10.1016\/j.dsx.2016.06.017"},{"key":"663_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/JAD-2010-100015","volume":"21","author":"V Frisardi","year":"2010","unstructured":"Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F (2010) Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 21:57\u201363. doi:\n                    10.3233\/JAD-2010-100015","journal-title":"J Alzheimers Dis"},{"key":"663_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ageing\/afv151","volume":"45","author":"E Pedditizi","year":"2016","unstructured":"Pedditizi E, Peters R, Beckett N (2016) The risk of overweight\/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. Age Ageing 45:14\u201321. doi:\n                    10.1093\/ageing\/afv151","journal-title":"Age Ageing"},{"key":"663_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.2174\/156720511796391818","volume":"8","author":"F Panza","year":"2011","unstructured":"Panza F, Frisardi V, Seripa D, Imbimbo BP, Sancarlo D, D\u2019Onofrio G, Addante F, Paris F et al (2011) Metabolic syndrome, mild cognitive impairment, and dementia. Curr Alzheimer Res 8:492\u2013509","journal-title":"Curr Alzheimer Res"},{"key":"663_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.12688\/f1000research.8300.2","volume":"5","author":"LE Stoeckel","year":"2016","unstructured":"Stoeckel LE, Arvanitakis Z, Gandy S, Small D, Kahn CR, Pascual-Leone A, Pawlyk A, Sherwin R et al (2016) Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction. F1000Res 5:353. doi:\n                    10.12688\/f1000research.8300.2","journal-title":"F1000Res"},{"key":"663_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neubiorev.2008.10.008","volume":"33","author":"DJ Lamport","year":"2009","unstructured":"Lamport DJ, Lawton CL, Mansfield MW, Dye L (2009) Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review. Neurosci Biobehav Rev 33:394\u2013413. doi:\n                    10.1016\/j.neubiorev.2008.10.008","journal-title":"Neurosci Biobehav Rev"},{"key":"663_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2014.04.001","volume":"42","author":"AA Miller","year":"2014","unstructured":"Miller AA, Spencer SJ (2014) Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun 42:10\u201321. doi:\n                    10.1016\/j.bbi.2014.04.001","journal-title":"Brain Behav Immun"},{"key":"663_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuroscience.2015.04.045","volume":"309","author":"AM Stranahan","year":"2015","unstructured":"Stranahan AM (2015) Models and mechanisms for hippocampal dysfunction in obesity and diabetes. Neuroscience 309:125\u2013139. doi:\n                    10.1016\/j.neuroscience.2015.04.045","journal-title":"Neuroscience"},{"key":"663_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest 127:1\u20134. doi:\n                    10.1172\/JCI92035","journal-title":"J Clin Invest"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dmrr.2531","volume":"31","author":"E Calvo-Ochoa","year":"2015","unstructured":"Calvo-Ochoa E, Arias C (2015) Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer\u2019s disease: studies in animal models. Diabetes Metab Res Rev 31:1\u201313. doi:\n                    10.1002\/dmrr.2531","journal-title":"Diabetes Metab Res Rev"},{"key":"663_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fnins.2015.00229","volume":"9","author":"N Castanon","year":"2015","unstructured":"Castanon N, Luheshi G, Laye S (2015) Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity. Front Neurosci 9:229. doi:\n                    10.3389\/fnins.2015.00229","journal-title":"Front Neurosci"},{"key":"663_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-2010-091669","volume":"21","author":"F Panza","year":"2010","unstructured":"Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D\u2019Onofrio G, Seripa D et al (2010) Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21:691\u2013724. doi:\n                    10.3233\/JAD-2010-091669","journal-title":"J Alzheimers Dis"},{"key":"663_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8:235\u2013253. doi:\n                    10.1038\/nrd2792","journal-title":"Nat Rev Drug Discov"},{"key":"663_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/med.21288","volume":"34","author":"M Katoh","year":"2014","unstructured":"Katoh M, Nakagama H (2014) FGF receptors: cancer biology and therapeutics. Med Res Rev 34:280\u2013300. doi:\n                    10.1002\/med.21288","journal-title":"Med Res Rev"},{"key":"663_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semcdb.2015.09.021","volume":"53","author":"KR Markan","year":"2016","unstructured":"Markan KR, Potthoff MJ (2016) Metabolic fibroblast growth factors (FGFs): mediators of energy homeostasis. Semin Cell Dev Biol 53:85\u201393. doi:\n                    10.1016\/j.semcdb.2015.09.021","journal-title":"Semin Cell Dev Biol"},{"key":"663_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fendo.2015.00193","volume":"6","author":"VJ Nies","year":"2015","unstructured":"Nies VJ, Sancar G, Liu W, van Zutphen T, Struik D, Yu RT, Atkins AR, Evans RM et al (2015) Fibroblast growth factor signaling in metabolic regulation. Front Endocrinol (Lausanne) 6:193. doi:\n                    10.3389\/fendo.2015.00193","journal-title":"Front Endocrinol (Lausanne)"},{"key":"663_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/cen.12095","volume":"78","author":"YC Woo","year":"2013","unstructured":"Woo YC, Xu A, Wang Y, Lam KS (2013) Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clin Endocrinol 78:489\u2013496. doi:\n                    10.1111\/cen.12095","journal-title":"Clin Endocrinol"},{"key":"663_CR20","doi-asserted-by":"publisher","first-page":"981315","DOI":"10.1155\/2011\/981315","volume":"2011","author":"Y Murata","year":"2011","unstructured":"Murata Y, Konishi M, Itoh N (2011) FGF21 as an endocrine regulator in lipid metabolism: from molecular evolution to physiology and pathophysiology. J Nutr Metab 2011:981315. doi:\n                    10.1155\/2011\/981315","journal-title":"J Nutr Metab"},{"key":"663_CR21","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","volume":"28","author":"H Hsuchou","year":"2007","unstructured":"Hsuchou H, Pan W, Kastin AJ (2007) The fasting polypeptide FGF21 can enter brain from blood. Peptides 28:2382\u20132386. doi:\n                    10.1016\/j.peptides.2007.10.007","journal-title":"Peptides"},{"key":"663_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4093\/dmj.2014.38.4.245","volume":"38","author":"KH Kim","year":"2014","unstructured":"Kim KH, Lee MS (2014) FGF21 as a stress hormone: the roles of FGF21 in stress adaptation and the treatment of metabolic diseases. Diabetes Metab J 38:245\u2013251. doi:\n                    10.4093\/dmj.2014.38.4.245","journal-title":"Diabetes Metab J"},{"key":"663_CR23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tem.2015.09.007","volume":"26","author":"A Kharitonenkov","year":"2015","unstructured":"Kharitonenkov A, DiMarchi R (2015) FGF21 revolutions: recent advances illuminating FGF21 biology and medicinal properties. Trends Endocrinol Metab 26:608\u2013617. doi:\n                    10.1016\/j.tem.2015.09.007","journal-title":"Trends Endocrinol Metab"},{"key":"663_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","volume":"18","author":"G Gaich","year":"2013","unstructured":"Gaich G, Chien JY, Fu H, Glass LC, Deeg MA, Holland WL, Kharitonenkov A, Bumol T et al (2013) The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab 18:333\u2013340. doi:\n                    10.1016\/j.cmet.2013.08.005","journal-title":"Cell Metab"},{"key":"663_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fendo.2015.00168","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Li Y (2015) Fibroblast growth factor 21 analogs for treating metabolic disorders. Front Endocrinol (Lausanne) 6:168. doi:\n                    10.3389\/fendo.2015.00168","journal-title":"Front Endocrinol (Lausanne)"},{"key":"663_CR26","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-15-0160","volume":"226","author":"KH Kim","year":"2015","unstructured":"Kim KH, Lee MS (2015) FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs. J Endocrinol 226:R1\u201316. doi:\n                    10.1530\/JOE-15-0160","journal-title":"J Endocrinol"},{"key":"663_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fendo.2015.00133","volume":"6","author":"A Planavila","year":"2015","unstructured":"Planavila A, Redondo-Angulo I, Villarroya F (2015) FGF21 and cardiac physiopathology. Front Endocrinol (Lausanne) 6:133. doi:\n                    10.3389\/fendo.2015.00133","journal-title":"Front Endocrinol (Lausanne)"},{"key":"663_CR28","doi-asserted-by":"publisher","first-page":"E1105","DOI":"10.1152\/ajpendo.00348.2009","volume":"297","author":"J Xu","year":"2009","unstructured":"Xu J, Stanislaus S, Chinookoswong N, Lau YY, Hager T, Patel J, Ge H, Weiszmann J et al (2009) Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models\u2014association with liver and adipose tissue effects. Am J Physiol Endocrinol Metab 297:E1105\u2013E1114. doi:\n                    10.1152\/ajpendo.00348.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"663_CR29","doi-asserted-by":"publisher","unstructured":"Li SM, Yu YH, Li L, Wang WF, Li DS (2015) Treatment of CIA mice with FGF21 down-regulates TH17-IL-17 axis. Inflammation. doi:\n                    10.1007\/s10753-015-0251-9","DOI":"10.1007\/s10753-015-0251-9"},{"key":"663_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148252","volume":"11","author":"G Singhal","year":"2016","unstructured":"Singhal G, Fisher FM, Chee MJ, Tan TG, El Ouaamari A, Adams AC, Najarian R, Kulkarni RN et al (2016) Fibroblast growth factor 21 (FGF21) protects against high fat diet induced inflammation and islet hyperplasia in pancreas. PLoS One 11:e0148252. doi:\n                    10.1371\/journal.pone.0148252","journal-title":"PLoS One"},{"key":"663_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pbb.2015.03.020","volume":"133","author":"Y Yu","year":"2015","unstructured":"Yu Y, Bai F, Wang W, Liu Y, Yuan Q, Qu S, Zhang T, Tian G et al (2015) Fibroblast growth factor 21 protects mouse brain against d-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation. Pharmacol Biochem Behav 133:122\u2013131. doi:\n                    10.1016\/j.pbb.2015.03.020","journal-title":"Pharmacol Biochem Behav"},{"key":"663_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cvr\/cvu263","volume":"106","author":"A Planavila","year":"2015","unstructured":"Planavila A, Redondo-Angulo I, Ribas F, Garrabou G, Casademont J, Giralt M, Villarroya F (2015) Fibroblast growth factor 21 protects the heart from oxidative stress. Cardiovasc Res 106:19\u201331. doi:\n                    10.1093\/cvr\/cvu263","journal-title":"Cardiovasc Res"},{"key":"663_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbrc.2015.02.081","volume":"459","author":"Y Joki","year":"2015","unstructured":"Joki Y, Ohashi K, Yuasa D, Shibata R, Ito M, Matsuo K, Kambara T, Uemura Y et al (2015) FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism. Biochem Biophys Res Commun 459:124\u2013130. doi:\n                    10.1016\/j.bbrc.2015.02.081","journal-title":"Biochem Biophys Res Commun"},{"key":"663_CR34","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/JOE-15-0289","volume":"227","author":"P Tanajak","year":"2015","unstructured":"Tanajak P, Chattipakorn SC, Chattipakorn N (2015) Effects of fibroblast growth factor 21 on the heart. J Endocrinol 227:R13\u2013R30. doi:\n                    10.1530\/JOE-15-0289","journal-title":"J Endocrinol"},{"key":"663_CR35","doi-asserted-by":"publisher","unstructured":"Sa-Nguanmoo P, Chattipakorn N, Chattipakorn SC (2016) Potential roles of fibroblast growth factor 21 in the brain. Metab Brain Dis. doi:\n                    10.1007\/s11011-015-9789-3","DOI":"10.1007\/s11011-015-9789-3"},{"key":"663_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1472-6750-10-14","volume":"10","author":"H Wang","year":"2010","unstructured":"Wang H, Xiao Y, Fu L, Zhao H, Zhang Y, Wan X, Qin Y, Huang Y et al (2010) High-level expression and purification of soluble recombinant FGF21 protein by SUMO fusion in Escherichia coli. BMC Biotechnol 10:14. doi:\n                    10.1186\/1472-6750-10-14","journal-title":"BMC Biotechnol"},{"key":"663_CR37","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/en.2006-1168","volume":"148","author":"A Kharitonenkov","year":"2007","unstructured":"Kharitonenkov A, Wroblewski VJ, Koester A, Chen YF, Clutinger CK, Tigno XT, Hansen BC, Shanafelt AB et al (2007) The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 148:774\u2013781. doi:\n                    10.1210\/en.2006-1168","journal-title":"Endocrinology"},{"key":"663_CR38","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1210\/en.2012-1211","volume":"153","author":"MM Veniant","year":"2012","unstructured":"Veniant MM, Komorowski R, Chen P, Stanislaus S, Winters K, Hager T, Zhou L, Wada R et al (2012) Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys. Endocrinology 153:4192\u20134203. doi:\n                    10.1210\/en.2012-1211","journal-title":"Endocrinology"},{"key":"663_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.physbeh.2016.02.007","volume":"157","author":"S Krishna","year":"2016","unstructured":"Krishna S, Lin Z, de La Serre CB, Wagner JJ, Harn DH, Pepples LM, Djani DM, Weber MT et al (2016) Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL\/6 mice caused by chronic high-fat diet intake. Physiol Behav 157:196\u2013208. doi:\n                    10.1016\/j.physbeh.2016.02.007","journal-title":"Physiol Behav"},{"key":"663_CR40","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1177\/0271678X15606724","volume":"36","author":"H Kim","year":"2016","unstructured":"Kim H, Kang H, Heo RW, Jeon BT, Yi CO, Shin HJ, Kim J, Jeong SY et al (2016) Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice. J Cereb Blood Flow Metab 36:1098\u20131110. doi:\n                    10.1177\/0271678X15606724","journal-title":"J Cereb Blood Flow Metab"},{"key":"663_CR41","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1073\/pnas.1006875108","volume":"108","author":"S Purkayastha","year":"2011","unstructured":"Purkayastha S, Zhang H, Zhang G, Ahmed Z, Wang Y, Cai D (2011) Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress. Proc Natl Acad Sci U S A 108:2939\u20132944. doi:\n                    10.1073\/pnas.1006875108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"663_CR42","doi-asserted-by":"publisher","unstructured":"Alawdi SH, El-Denshary ES, Safar MM, Eidi H, David MO, Abdel-Wahhab MA (2016) Neuroprotective effect of nanodiamond in Alzheimer\u2019s disease rat model: a pivotal role for modulating NF-kappaB and STAT3 signaling. Mol Neurobiol. doi:\n                    10.1007\/s12035-016-9762-0","DOI":"10.1007\/s12035-016-9762-0"},{"key":"663_CR43","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ijo.2010.59","volume":"34","author":"VA Gault","year":"2010","unstructured":"Gault VA, Porter WD, Flatt PR, Holscher C (2010) Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet. Int J Obes 34:1341\u20131344. doi:\n                    10.1038\/ijo.2010.59","journal-title":"Int J Obes"},{"key":"663_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2014.03.012","volume":"41","author":"C Andre","year":"2014","unstructured":"Andre C, Dinel AL, Ferreira G, Laye S, Castanon N (2014) Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation. Brain Behav Immun 41:10\u201321. doi:\n                    10.1016\/j.bbi.2014.03.012","journal-title":"Brain Behav Immun"},{"key":"663_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.18632\/aging.100738","volume":"7","author":"RA van der Heijden","year":"2015","unstructured":"van der Heijden RA, Sheedfar F, Morrison MC, Hommelberg PP, Kor D, Kloosterhuis NJ, Gruben N, Youssef SA et al (2015) High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL\/6j mice. Aging (Albany NY) 7:256\u2013268. doi:\n                    10.18632\/aging.100738","journal-title":"Aging (Albany NY)"},{"key":"663_CR46","doi-asserted-by":"publisher","unstructured":"Liu L, Duff K (2008) A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse. J Vis Exp. doi:\n                    10.3791\/960","DOI":"10.3791\/960"},{"key":"663_CR47","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/nm.4188","volume":"22","author":"YK Choi","year":"2016","unstructured":"Choi YK, Maki T, Mandeville ET, Koh SH, Hayakawa K, Arai K, Kim YM, Whalen MJ et al (2016) Dual effects of carbon monoxide on pericytes and neurogenesis in traumatic brain injury. Nat Med 22:1335\u20131341. doi:\n                    10.1038\/nm.4188","journal-title":"Nat Med"},{"key":"663_CR48","doi-asserted-by":"publisher","first-page":"139239","DOI":"10.1155\/2013\/139239","volume":"2013","author":"K Makki","year":"2013","unstructured":"Makki K, Froguel P, Wolowczuk I (2013) Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013:139239. doi:\n                    10.1155\/2013\/139239","journal-title":"ISRN Inflamm"},{"key":"663_CR49","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tem.2012.11.003","volume":"24","author":"D Cai","year":"2013","unstructured":"Cai D (2013) Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab 24:40\u201347. doi:\n                    10.1016\/j.tem.2012.11.003","journal-title":"Trends Endocrinol Metab"},{"key":"663_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1742-2094-10-114","volume":"10","author":"RA Kohman","year":"2013","unstructured":"Kohman RA, Bhattacharya TK, Wojcik E, Rhodes JS (2013) Exercise reduces activation of microglia isolated from hippocampus and brain of aged mice. J Neuroinflammation 10:114. doi:\n                    10.1186\/1742-2094-10-114","journal-title":"J Neuroinflammation"},{"key":"663_CR51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12035-014-8632-x","volume":"50","author":"AK Datusalia","year":"2014","unstructured":"Datusalia AK, Sharma SS (2014) Amelioration of diabetes-induced cognitive deficits by GSK-3beta inhibition is attributed to modulation of neurotransmitters and neuroinflammation. Mol Neurobiol 50:390\u2013405. doi:\n                    10.1007\/s12035-014-8632-x","journal-title":"Mol Neurobiol"},{"key":"663_CR52","doi-asserted-by":"publisher","unstructured":"Ahmad A, Ali T, Park HY, Badshah H, Rehman SU, Kim MO (2016) Neuroprotective effect of fisetin against amyloid-beta-induced cognitive\/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult mice. Mol Neurobiol. doi:\n                    10.1007\/s12035-016-9795-4","DOI":"10.1007\/s12035-016-9795-4"},{"key":"663_CR53","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbi.2015.08.023","volume":"51","author":"S Hao","year":"2016","unstructured":"Hao S, Dey A, Yu X, Stranahan AM (2016) Dietary obesity reversibly induces synaptic stripping by microglia and impairs hippocampal plasticity. Brain Behav Immun 51:230\u2013239. doi:\n                    10.1016\/j.bbi.2015.08.023","journal-title":"Brain Behav Immun"},{"key":"663_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004791","volume":"95","author":"CK Tsai","year":"2016","unstructured":"Tsai CK, Kao TW, Lee JT, Wu CJ, Hueng DY, Liang CS, Wang GC, Yang FC et al (2016) Increased risk of cognitive impairment in patients with components of metabolic syndrome. Medicine (Baltimore) 95:e4791. doi:\n                    10.1097\/MD.0000000000004791","journal-title":"Medicine (Baltimore)"},{"key":"663_CR55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11892-014-0495-z","volume":"14","author":"ML Alosco","year":"2014","unstructured":"Alosco ML, Gunstad J (2014) The negative effects of obesity and poor glycemic control on cognitive function: a proposed model for possible mechanisms. Curr Diab Rep 14:495. doi:\n                    10.1007\/s11892-014-0495-z","journal-title":"Curr Diab Rep"},{"key":"663_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2337\/db08-0392","volume":"58","author":"J Xu","year":"2009","unstructured":"Xu J, Lloyd DJ, Hale C, Stanislaus S, Chen M, Sivits G, Vonderfecht S, Hecht R et al (2009) Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes 58:250\u2013259. doi:\n                    10.2337\/db08-0392","journal-title":"Diabetes"},{"issue":"Pt 1","key":"663_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.mce.2015.09.018","volume":"418","author":"M Giralt","year":"2015","unstructured":"Giralt M, Gavalda-Navarro A, Villarroya F (2015) Fibroblast growth factor-21, energy balance and obesity. Mol Cell Endocrinol 418(Pt 1):66\u201373. doi:\n                    10.1016\/j.mce.2015.09.018","journal-title":"Mol Cell Endocrinol"},{"key":"663_CR58","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/gps.4245","volume":"30","author":"K Deckers","year":"2015","unstructured":"Deckers K, van Boxtel MP, Schiepers OJ, de Vugt M, Munoz Sanchez JL, Anstey KJ, Brayne C, Dartigues JF et al (2015) Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 30:234\u2013246. doi:\n                    10.1002\/gps.4245","journal-title":"Int J Geriatr Psychiatry"},{"key":"663_CR59","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop B, Elte JW, Cabezas MC (2013) Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 5:1218\u20131240. doi:\n                    10.3390\/nu5041218","journal-title":"Nutrients"},{"key":"663_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/EJE-12-0357","volume":"167","author":"P Iglesias","year":"2012","unstructured":"Iglesias P, Selgas R, Romero S, Diez JJ (2012) Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21. Eur J Endocrinol 167:301\u2013309. doi:\n                    10.1530\/EJE-12-0357","journal-title":"Eur J Endocrinol"},{"key":"663_CR61","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1210\/en.2010-1262","volume":"153","author":"C Hale","year":"2012","unstructured":"Hale C, Chen MM, Stanislaus S, Chinookoswong N, Hager T, Wang M, Veniant MM, Xu J (2012) Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Endocrinology 153:69\u201380. doi:\n                    10.1210\/en.2010-1262","journal-title":"Endocrinology"},{"key":"663_CR62","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","volume":"59","author":"FM Fisher","year":"2010","unstructured":"Fisher FM, Chui PC, Antonellis PJ, Bina HA, Kharitonenkov A, Flier JS, Maratos-Flier E (2010) Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 59:2781\u20132789. doi:\n                    10.2337\/db10-0193","journal-title":"Diabetes"},{"key":"663_CR63","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1210\/me.2007-0313","volume":"22","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, Uehara Y, Motomura-Matsuzaka K, Oki J, Koyama Y, Kimura M, Asada M, Komi-Kuramochi A et al (2008) betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol Endocrinol 22:1006\u20131014. doi:\n                    10.1210\/me.2007-0313","journal-title":"Mol Endocrinol"},{"key":"663_CR64","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1210\/me.2010-0142","volume":"24","author":"K Fon Tacer","year":"2010","unstructured":"Fon Tacer K, Bookout AL, Ding X, Kurosu H, John GB, Wang L, Goetz R, Mohammadi M et al (2010) Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol Endocrinol 24:2050\u20132064. doi:\n                    10.1210\/me.2010-0142","journal-title":"Mol Endocrinol"},{"key":"663_CR65","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3249","volume":"19","author":"AL Bookout","year":"2013","unstructured":"Bookout AL, de Groot MH, Owen BM, Lee S, Gautron L, Lawrence HL, Ding X, Elmquist JK et al (2013) FGF21 regulates metabolism and circadian behavior by acting on the nervous system. Nat Med 19:1147\u20131152. doi:\n                    10.1038\/nm.3249","journal-title":"Nat Med"},{"key":"663_CR66","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.2337\/db14-0541","volume":"63","author":"Q Liang","year":"2014","unstructured":"Liang Q, Zhong L, Zhang J, Wang Y, Bornstein SR, Triggle CR, Ding H, Lam KS et al (2014) FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting. Diabetes 63:4064\u20134075. doi:\n                    10.2337\/db14-0541","journal-title":"Diabetes"},{"key":"663_CR67","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.2337\/db11-0672","volume":"60","author":"BK Tan","year":"2011","unstructured":"Tan BK, Hallschmid M, Adya R, Kern W, Lehnert H, Randeva HS (2011) Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity. Diabetes 60:2758\u20132762. doi:\n                    10.2337\/db11-0672","journal-title":"Diabetes"},{"key":"663_CR68","doi-asserted-by":"publisher","unstructured":"Du L, Zhang Y, Chen Y, Zhu J, Yang Y, Zhang HL (2016) Role of microglia in neurological disorders and their potentials as a therapeutic target. Mol Neurobiol. doi:\n                    10.1007\/s12035-016-0245-0","DOI":"10.1007\/s12035-016-0245-0"},{"key":"663_CR69","doi-asserted-by":"publisher","unstructured":"Jope RS, Cheng Y, Lowell JA, Worthen RJ, Sitbon YH, Beurel E (2016) Stressed and inflamed, can GSK3 be blamed? Trends Biochem Sci. doi:\n                    10.1016\/j.tibs.2016.10.009","DOI":"10.1016\/j.tibs.2016.10.009"},{"key":"663_CR70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbr.2017.01.035","volume":"323","author":"Q Mao","year":"2017","unstructured":"Mao Q, Gong X, Zhou C, Tu Z, Zhao L, Wang L, Wang X, Sun L et al (2017) Up-regulation of SIRT6 in the hippocampus induced rats with depression-like behavior via the block Akt\/GSK3beta signaling pathway. Behav Brain Res 323:38\u201346. doi:\n                    10.1016\/j.bbr.2017.01.035","journal-title":"Behav Brain Res"},{"key":"663_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","volume":"67","author":"SE Arnold","year":"2014","unstructured":"Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, Bang S, Choi BR et al (2014) High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis 67:79\u201387. doi:\n                    10.1016\/j.nbd.2014.03.011","journal-title":"Neurobiol Dis"},{"key":"663_CR72","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1523\/JNEUROSCI.4200-13.2014","volume":"34","author":"JR Erion","year":"2014","unstructured":"Erion JR, Wosiski-Kuhn M, Dey A, Hao S, Davis CL, Pollock NK, Stranahan AM (2014) Obesity elicits interleukin 1-mediated deficits in hippocampal synaptic plasticity. J Neurosci 34:2618\u20132631. doi:\n                    10.1523\/JNEUROSCI.4200-13.2014","journal-title":"J Neurosci"},{"key":"663_CR73","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev-neuro-071013-014134","volume":"37","author":"KM Christian","year":"2014","unstructured":"Christian KM, Song H, Ming GL (2014) Functions and dysfunctions of adult hippocampal neurogenesis. Annu Rev Neurosci 37:243\u2013262. doi:\n                    10.1146\/annurev-neuro-071013-014134","journal-title":"Annu Rev Neurosci"},{"key":"663_CR74","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.2174\/1568026615666150610141524","volume":"15","author":"C Vivar","year":"2015","unstructured":"Vivar C (2015) Adult hippocampal neurogenesis, aging and neurodegenerative diseases: possible strategies to prevent cognitive impairment. Curr Top Med Chem 15:2175\u20132192","journal-title":"Curr Top Med Chem"},{"key":"663_CR75","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2010.07.046","volume":"482","author":"HR Park","year":"2010","unstructured":"Park HR, Park M, Choi J, Park KY, Chung HY, Lee J (2010) A high-fat diet impairs neurogenesis: Involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci Lett 482:235\u2013239. doi:\n                    10.1016\/j.neulet.2010.07.046","journal-title":"Neurosci Lett"},{"key":"663_CR76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nlm.2016.03.002","volume":"131","author":"C Klein","year":"2016","unstructured":"Klein C, Jonas W, Iggena D, Empl L, Rivalan M, Wiedmer P, Spranger J, Hellweg R et al (2016) Exercise prevents high-fat diet-induced impairment of flexible memory expression in the water maze and modulates adult hippocampal neurogenesis in mice. Neurobiol Learn Mem 131:26\u201335. doi:\n                    10.1016\/j.nlm.2016.03.002","journal-title":"Neurobiol Learn Mem"},{"key":"663_CR77","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yhbeh.2016.08.006","volume":"85","author":"P Sa-Nguanmoo","year":"2016","unstructured":"Sa-Nguanmoo P, Tanajak P, Kerdphoo S, Satjaritanun P, Wang X, Liang G, Li X, Jiang C et al (2016) FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats. Horm Behav 85:86\u201395. doi:\n                    10.1016\/j.yhbeh.2016.08.006","journal-title":"Horm Behav"},{"key":"663_CR78","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11011-015-9789-3","volume":"31","author":"P Sa-Nguanmoo","year":"2016","unstructured":"Sa-Nguanmoo P, Chattipakorn N, Chattipakorn SC (2016) Potential roles of fibroblast growth factor 21 in the brain. Metab Brain Dis 31:239\u2013248. doi:\n                    10.1007\/s11011-015-9789-3","journal-title":"Metab Brain Dis"},{"key":"663_CR79","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.diabres.2015.02.032","volume":"108","author":"JJ Liu","year":"2015","unstructured":"Liu JJ, Foo JP, Liu S, Lim SC (2015) The role of fibroblast growth factor 21 in diabetes and its complications: a review from clinical perspective. Diabetes Res Clin Pract 108:382\u2013389. doi:\n                    10.1016\/j.diabres.2015.02.032","journal-title":"Diabetes Res Clin Pract"},{"key":"663_CR80","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/oby.2007.608","volume":"15","author":"R Buettner","year":"2007","unstructured":"Buettner R, Scholmerich J, Bollheimer LC (2007) High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15:798\u2013808. doi:\n                    10.1038\/oby.2007.608","journal-title":"Obesity (Silver Spring)"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0663-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0663-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0663-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:36:31Z","timestamp":1589733391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0663-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0663-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,15]]},"assertion":[{"value":"23 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed following protocols approved by the Massachusetts General Hospital Institutional Animal Care and Use Committee in compliance with the NIH Guide for the Care and Use of Laboratory Animals. All efforts were exerted to minimize animal suffering.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}